Dana-Farber research helps drive FDA label update for primary CNS lymphoma - EurekAlert!
FDA approves immune checkpoint inhibitor drug for patients with resectable locally advanced head and neck cancer, backed by Dana-Farber research - EurekAlert!
Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025 - EurekAlert!
Endometrial, lung, and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2024 - EurekAlert
